AZN

阿斯利康

This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

阿斯利康

AZN

0.00%
92.77

麥克森

MCK

+1.79%
760.57

生物基因

BIIB

+0.83%
192.95

A

Amgen Inc

AMGN

-2.22%
326.31

沙爾製藥

SHPG

0.00%
179.20

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+24.64%
0.1295

禮來

LLY

-0.01%
--

新基醫藥

CELG

0.00%
108.24

T

Therapeuticsmd Inc

TXMD

+1.96%
2.080

強生

JNJ

-1.77%
226.71

艾伯維

ABBV

-0.18%
210.39

碩騰

ZTS

-1.67%
74.22

G

Gilead Sciences Inc

GILD

-1.88%
129.58

N

Novo-Nordisk A/S

NVO

-2.31%
44.74

B

Bristol-Myers Squibb Co

BMY

+0.41%
57.00

輝瑞製藥

PFE

-1.63%
25.33

亞力兄製藥

ALXN

+1.70%
182.50

S

Sanofi FR

GCVRZ

0.00%
0.8711

賽諾菲

SNY

-0.37%
42.69

諾華製藥

NVS

-1.13%
148.08

如瑞迪博士

RDY

+0.89%
13.61

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.